Self-biting induced by activation of L-type calcium channels in mice: Serotonergic influences

Developmental Neuroscience

Volumn 24, Issue 4, 2002, Pages 322-327

  Kasim, Suhail ^a   Egami, Kiyoshi ^a   Jinnah, H A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Calcium channel; Mouse; Self injurious behavior; Serotonin

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 5,7 DIHYDROXYTRYPTAMINE; CALCIUM CHANNEL L TYPE; CLORGYLINE; FENCLONINE; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AUTOMUTILATION; BITE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SEROTONINERGIC SYSTEM;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; 5,7-DIHYDROXYTRYPTAMINE; ANIMALS; BRAIN; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; CLORGYLINE; FEMALE; FENCLONINE; FLUOXETINE; MALE; MICE; MICE, INBRED C57BL; MONOAMINE OXIDASE INHIBITORS; SELF MUTILATION; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0036446184     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066747     Document Type: Article

References (41)

1. Schroeder SR, Oster-Granite ML, Thompson T: Self-injurious Behavior: Gene-brain-behavior Relationships. Washington, American Psychological Association, 2002.
2. Pies RW, Popli AP: Self-injurious behavior: Pathophysiology and implications for treatment. J Clin Psychiatry 1995;56:580-588.
3. King BH: Self-injury by people with mental retardation: A compulsive behavior hypothesis. Am J Ment Retard 1993;98:93-112.
4. Van Praag HM, Plutchik R, Conte H: The serotonin hypothesis of (auto)aggression: Critical appraisal of the evidence. Ann N Y Acad Sci 1986;487:150-167.
5. Winchel RM, Stanley M: Self-injurious behavior: A review of the behavior and biology of self-mutilation. Am J Psychiatry 1991;148:306-317.
6. Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL: A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989;321:497-501.
7. Leonard HL, Lenane MC, Swedo SE, Rettew DC, Rapoport JL: A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). Arch Gen Psychiatry 1991;48:821-827.
8. Primeau F, Fontaine R: Obsessive disorder with self-mutilation: A subgroup responsive to pharmacotherapy. Can J Psychiat 1987;32:699-701.
9. Markowitz PI: Effect of fluoxetine on self-injurious behavior in the developmentally disabled: A preliminary study. J Clin Psychopharmacol 1992;12:27-31.
10. Davanzo PA, Belin TR, Widawski MH, King BH: Paroxetine treatment of aggression and self-injury in persons with mental retardation. Am J Ment Retard 1998;102:427-437.
11. Warnock JK, Kestenbaum T: Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Arch Dermatol 1992;128:1623-1625.
12. Kirkpatrick-Sanchez S, Williams DE, Gualtieri CT, Raichman JA: Case report: The effects of selective serotonergic reuptake inhibitors combined with behavioral treatment on self-injury associated with Lesch-Nyhan syndrome. J Dev Phys Disabil 1998;10:283-290.
13. Mizuno T, Yugary Y: Prophylactic effect of L-5-hydroxytryptophan on self-mutilation in the Lesch-Nyhan syndrome. Neuropediatrics 1975;6:13-23.
14. Barry RG, Buckley BM, Tully ER: Clinical and biochemical observations on a patient with the Lesch-Nyhan syndrome. Ir J Med Sci 1978;147:213-215.
15. Castells S, Chakrabarti C, Winsberg BG, Hurwic M, Perel JM, Nyhan WL: Effect of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome. J Autism Dev Disord 1979;9:95-103.
16. Nyhan WL, Johnson HG, Kaufman IA, Jones KL: Serotonergic approaches to the modification of behavior in the Lesch-Nyhan syndrome. Appl Res Ment Retard 1980;1:25-20.
17. Weld KP, Mench JA, Woodward RA, Bolesta MS, Suomi SJ, Higley JD: Effect of tryptophan treatment on self-biting and central nervous system serotonin metabolism in Rhesus monkeys. Neuropsychopharmacology 1998;19:314-321.
18. Shishido T, Watanabe Y, Kato K, Horikoshi R, Niwa SI: Effects of dopamine, NMDA, opiate, and serotonin-related agents on acute methamphetamine-induced self-injurious behavior in mice. Pharmacol Biochem Behav 2000;66:579-583.
19. Turner C, Panksepp J, Bekkedal M, Borkowski C, Burgdorf J: Paradoxical effects of serotonin and opioids in pemoline-induced self-injurious behavior. Pharmacol Biochem Behav 1999;63:361-366.
20. Bhattacharya SK, Jaiswal AK, Mukhopadhyay M, Datla KP: Clonidine-induced automutilation in mice as a laboratory model for clinical self-injurious behavior. J Psychiatr Res 1988;22:43-50.
21. Berger TW, Kaul S, Stricker EM, Zigmond MJ: Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res 1985;336:354-358.
22. Luthman J, Bolioli B, Tsutsumi T, Verhofstad A, Jonsson G: Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Brain Res Bull 1987;19:269-274.
23. Snyder AM, Zigmond MJ, Lund RD: Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: A retrograde transport and immunocytochemical study. J Comp Neurol 1986;245:274-281.
24. Stachowiak MK, Bruno JP, Snyder AM, Strick-er EM, Zigmond MJ: Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res 1984;291:164-167.
25. Towle AC, Criswell HE, Maynard EH, Lauder JM, Joh TH, Mueller RA, Breese GR: Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: An anatomical, biochemical and phamacological study. Pharmacol Biochem Behav 1989;34:367-374.
26. Allen SM, Davis WM: Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome. Behav Pharmacol 1999;10:467-474.
27. Jinnah HA, Yitta S, Drew T, Kim BS, Visser JE, Rothstein JD: Calcium channel activation and self-biting in mice. Proc Natl Acad Sci USA 1999;96:15228-15232.
28. Kasim S, Jinnah HA: Thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease. Pharmacol Biochem Behav, in press.
29. Koe KB, Weissman A: p-Chlorophenylalanine: A specific depletor of brain serotonin. J Pharmacol Exp Ther 1966;154:499-516.
30. Muramoto O, Kanazawa I, Ando K: Neurotransmitter abnormality in rolling mouse Nagoya, an ataxic mutant mouse. Brain Res 1981;215:295-305.
31. Towle AC, Breese GR, Mueller RA, Coyle S, Lauder JM: Early postnatal administration of 5,7-DHT: Effects on serotonergic neurons and terminals. Brain Res 1984;310:67-75.
32. Jinnah HA, Jones MD, Wojcik BE, Rothstein JD, Hess EJ, Friedmann T, Breese GR: Influence of age and strain on striatal dopamine loss in a genetic mouse model of Lesch-Nyhan disease. J Neurochem 1999;72:225-229.
33. Fray PJ, Sahakian BJ, Robbins TW, Koob GF, Iversen SD: An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-amphetamine and apomorphine. Psychopharmacology 1980;69:253-259.
34. Finberg JP, Youdim MB: Selective MAO A and MAO B inhibitors: Their mechanism of action and pharmacology. Neuropharmacology 1983;22:441-446.
35. Fuller RW: Serotonin uptake inhibitors: Uses in clinical therapy and in laboratory research. Prog Drug Res 1995;45:167-204.
36. Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch Pharmacol 1972;275:153-168.
37. Fickbohm DJ, Katz PS: Paradoxical actions of the serotonin precursor 5-hydroxytryptophan on the activity of identified serotonergic neurons in a simple motor circuit. J Neurosci 2000;20:162-1634.
38. Triggle DJ, Rampe D: 1,4-Dihydropyridine activators and antagonists: Structural and functional distinctions. Trends Pharmacol Sci 1988;10:507-511.
39. Barnes NM, Sharp T: A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083-1152.
40. Bolger GT, Lesieur P, Basile AS, Skolnick P: Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain. Brain Res 1988;438:101-107.
41. Colado MI, Ormazabal MJ, Alfaro MJ, Martin MI: Effect of Bay K 8644 on the synthesis and metabolism of dopamine and 5-hydroxytryptamine in various brain areas of the rat. J Pharm Pharmacol 1993;45:220-222.